| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/ACI.0B013E328355365A |
| P698 | PubMed publication ID | 22766620 |
| P50 | author | Marcus Maurer | Q50039778 |
| Martin Metz | Q37838546 | ||
| P433 | issue | 4 | |
| P921 | main subject | urticaria | Q187440 |
| chronic urticaria | Q3886240 | ||
| P304 | page(s) | 406-411 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Current Opinion in Allergy and Clinical Immunology | Q1858992 |
| P1476 | title | Omalizumab in chronic urticaria | |
| P478 | volume | 12 |
| Q33588223 | Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin |
| Q52661824 | Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update. |
| Q55209892 | Detection and allergen analysis of serum IgE in pediatric patients with chronic urticaria. |
| Q42753216 | Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema |
| Q52804420 | Immunoglobulin E-Mediated Autoimmunity. |
| Q42976598 | Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases |
| Q37634329 | Omalizumab in an allergology clinic: real life experience and future developments |
| Q38248806 | Omalizumab: a review of its use in patients with chronic spontaneous urticaria |
| Q30249703 | Questions and answers in chronic urticaria: where do we stand and where do we go? |
| Q37121967 | Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria |
| Q39387473 | Review of Physical Urticarias and Testing Methods |
| Q38208428 | The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update |
| Q39168827 | Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases. |
Search more.